Novo Nordisk | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
ANI Pharmaceuticals USD 217.8M 67.99M 2025-06
Aurora Cannabis CAD 108.71M 23.79M 2024-12
Bausch Health Companies USD 1.73B 593M 2025-06
Bristol-Myers Squibb USD 12.6B 1.72B 2025-06
Canopy Growth CAD 16.31M 69.8M 2024-12
Corcept Therapeutics USD 102.74M 12.93M 2025-06
Drreddys Laboratories INR 1.1B 743M 2024-12
Eli Lilly USD 3.38B 282.6M 2025-06
GlaxoSmithKline GBP 3.6B 865M 2025-06
Merck USD 8.01B 622M 2025-06
Novartis USD 6.66B 410M 2025-06
Novo Nordisk 38.94B 18.08B 2025-03
Novo Nordisk A/S 18.44B 5.78B 2025-06
Pacira USD 300.48M 16.87M 2025-06
Perrigo USD 454.2M 44.3M 2025-06
Prestige Brands USD 139.5M 41.62M 2025-06
Sanofi 15.36B 7.37B 2025-06
Supernus Pharmaceuticals USD 144.71M 28.86M 2025-06
Zoetis USD 1.44B 286M 2025-06


Novo Nordisk Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.